Skip to Main Content

Paper Details

CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomised trials.
BMJ
32
2023
Author NameAffiliation
Joel J GagnierWestern University
David MoherClinical Epidemiology Programme, Ottawa Hospital Research Institute
David MoherUniversity of Ottawa
John P A IoannidisStanford University
John P A IoannidisStanford University
  • 1 - 5

Datasets

Release 1.2